Link to this page
Medical Subject Headings
| Preferred Name | Linagliptin | |
| Synonyms |
Trajenta 1H-purine-2,6-dione, 8-((3r)-3-amino-1-piperidinyl)-7-(2-butynyl)-3,7-dihydro-3-methyl-1-((4-methyl-2-quinazolinyl)methyl)- Tradjenta (R)-8-(3-amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione BI1356 BI 1356 BI-1356 1356, BI |
|
| Definitions |
A purine and quinazoline derivative that functions as an INCRETIN and DIPEPTIDYL-PEPTIDASE IV INHIBTOR. It is used as a HYPOGLYCEMIC AGENT in the treatment of TYPE II DIABETES MELLITUS. |
|
| ID |
http://purl.bioontology.org/ontology/MESH/D000069476 |
|
| altLabel |
Trajenta 1H-purine-2,6-dione, 8-((3r)-3-amino-1-piperidinyl)-7-(2-butynyl)-3,7-dihydro-3-methyl-1-((4-methyl-2-quinazolinyl)methyl)- Tradjenta (R)-8-(3-amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione BI1356 BI 1356 BI-1356 1356, BI
|
|
| AQL |
AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR
|
|
| cui |
C3153996 C2352547 C2746078
|
|
| DC |
1
|
|
| definition |
A purine and quinazoline derivative that functions as an INCRETIN and DIPEPTIDYL-PEPTIDASE IV INHIBTOR. It is used as a HYPOGLYCEMIC AGENT in the treatment of TYPE II DIABETES MELLITUS.
|
|
| DX |
20160101
|
|
| FX |
D000068900
|
|
| HN |
2016 (2011)
|
|
| Inverse of AQ |
http://purl.bioontology.org/ontology/MESH/Q000097 http://purl.bioontology.org/ontology/MESH/Q000627 http://purl.bioontology.org/ontology/MESH/Q000493 http://purl.bioontology.org/ontology/MESH/Q000494 http://purl.bioontology.org/ontology/MESH/Q000276 http://purl.bioontology.org/ontology/MESH/Q000138 http://purl.bioontology.org/ontology/MESH/Q000134 http://purl.bioontology.org/ontology/MESH/Q000266 http://purl.bioontology.org/ontology/MESH/Q000378 http://purl.bioontology.org/ontology/MESH/Q000008 http://purl.bioontology.org/ontology/MESH/Q000009 http://purl.bioontology.org/ontology/MESH/Q000031 http://purl.bioontology.org/ontology/MESH/Q000032 http://purl.bioontology.org/ontology/MESH/Q000037 http://purl.bioontology.org/ontology/MESH/Q000191 http://purl.bioontology.org/ontology/MESH/Q000302 http://purl.bioontology.org/ontology/MESH/Q000145 http://purl.bioontology.org/ontology/MESH/Q000592 http://purl.bioontology.org/ontology/MESH/Q000737 http://purl.bioontology.org/ontology/MESH/Q000819 http://purl.bioontology.org/ontology/MESH/Q000506 http://purl.bioontology.org/ontology/MESH/Q000633 http://purl.bioontology.org/ontology/MESH/Q000600 |
|
| Inverse of RB |
3X29ZEJ4R2 0
|
|
| Inverse of RO | ||
| isa |
http://purl.bioontology.org/ontology/MESH/D007004 |
|
| LT |
TRD
|
|
| Machine permutation |
2016; LINAGLIPTIN was indexed under PURINES and QUINAZOLINES 2011-2015
|
|
| MDA |
20150706
|
|
| MMR |
20160531
|
|
| MN |
D03.633.100.786.563 D03.633.100.759.562
|
|
| notation |
D000069476
|
|
| PA |
D054873 D007004 D054795
|
|
| prefLabel |
Linagliptin
|
|
| RR |
668270-12-0
|
|
| TERMUI |
T000882417 T000881334 T717181 T717182 T000880313 T000882419 T717180 T764527
|
|
| TH |
NLM (2016) NLM (2008) FDA SRS (2013) NLM (2012) USAN (19XX) NLM (2010)
|
|
| tui |
T109 T121
|
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |